Skip to Main Content

Paper Details

Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response.
Clin Cancer Res
192
2016
Glioblastoma, Recurrent, VEGF, bevacizumab, brain tumors, cancer, patients, recurrent glioblastoma, superpc signature, tumor
Author NameAffiliation
John MuschelliJohns Hopkins Bloomberg School of Public Health
Russell T ShinoharaCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania
Martin Sill
Martha NowosielskiThe Medical University of Innsbruck
  • 1 - 4

Datasets

Release 1.2